UNSPSC 51151660: Piperidolate

This classification denotes a diphenylacetic acid and piperidine with the molecular formula C21H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RJO31255V9, chemically known as 3-piperidinol, 1-ethyl-, diphenylacetate (ester) but generally known as piperidolate, which bears US NIH Compound Identifier 4839. European Medicines Agency schedules Piperidolate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09870MIG.

UNSPSC 51151660 Piperidolate is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023—solicits naloxone and drug deactivation systems for community health initiatives, not piperidolate pharmaceutical products. The mismatch suggests either a coding error in the source data or a broadening of the code's application to cover opioid-response medications and related harm-reduction equipment beyond the chemical compound itself.

The code shows minimal recent activity relevant to its stated pharmaceutical scope. Seminole County's naloxone procurement calls for 1,900 units annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under an IFB with electronic bidding through the county's e-Procurement Portal. The contract structure includes a two-year initial term with a one-year renewal option, E-Verify and drug-free workplace compliance requirements, and potential FEMA funding with attendant federal environmental compliance obligations. Without additional recent opportunities tagged to this code, visibility into geographic spread, issuing-body mix, or market concentration remains limited.